 |
|
|
|
|
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Colton C, Vitek M, Wink D. on PAPER: Kummer MP. et al., 2011, The Case for Personalized Alzheimer’s Medicine
Heneka and colleagues’ new report on... 10 Sep 2011.
|
|
|
 |
|
|
Vitek M. on NEWS: Mark Smith, 45, Is Struck and Killed by Hit-and-Run Driver, No number of words can convey the impact that Mark's loss will have on our field.
Mark... 5 Jan 2011.
|
|
|
|
|
|
Colton C, Vitek M, Wink D. on PAPER: Puzzo D. et al., 2009, This study on sildenafil by Puzzo, Arancio, and others provides intriguing insight into the role... 30 Jun 2009.
|
|
|
|
|
|
Colton C, Vitek M. on NEWS: Brain Drain—E4 Less Stable Than Other ApoE Isoforms, Compelling and widely accepted genetic evidence shows that the presence of one or more APOE4... 7 Nov 2008.
|
|
|
|
|
|
Colton C, Vitek M. on NEWS: Aβ and Phospho-tau: Strange Bedfellows Get Intimate at Synapses, My colleague and I would also like to echo the importance of the connection between amyloid,... 30 Sep 2008.
|
|
|
|
|
|
Colton C, Van Nostrand W, Vitek M, Wilcock D. on PAPER: Wilcock DM. et al., 2008, Reply by CA Colton, DM Wilcock, J Oddo, WE Van Nostrand, MP Vitek, and D... 13 Mar 2008.
|
|
|
|
|
|
Colton C, Vitek M, Wilcock D. on NEWS: Popcorn Plaque? Alzheimer Disease Is Slow, Yet Plaque Growth Is Fast, Meyer-Luehmann and colleagues provide new insights into the temporal sequence of events... 14 Feb 2008.
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our most recent Webinar: 
